Description
STUDY SCOPE
This report will help you
- Identify the top NGS applications
- Pinpoint the NGS applications with the greatest potential for growth in 2014
- Explore the range of biological samples used for NGS analysis
- Estimate the number of researchers and labs currently performing NGS
- Determine annual lab budgets associated with NGS sample and library preparation products
- Approximate supplier share by laboratory spending
- Assess market growth in terms of budget allocation in the next 12 months (through 2014)
- Identify the leading suppliers of NGS library preparation products by NGS application
- Gauge customer satisfaction, loyalty and likelihood to reorder NGS library preparation products
- Recognize key drivers of customer satisfaction for NGS library preparation products
- Anticipate the bottlenecks associated with NGS library preparation
- Assess the adoption of laboratory automation for NGS library preparation
- Discover the role of NGS service providers vis-à-vis sample preparation
OVERVIEW
Next generation sequencing (NGS) is a disruptive technology with an ever-increasing number of users and applications. As such, it is the fastest growing and most attractive segment of all the different technologies that comprise the genomics universe. On a global scale, we estimate that about 19% of life science researchers perform NGS in their work.
At the core of every cutting edge technology are the tools required to execute it, and next generation sequencing is no exception. Much of the hype surrounding NGS has centered on the instruments—ranging from benchtop models to those with production-scale capacity.
It is thanks to these tools that NGS has become a reality, allowing researchers to identify genomes, transcriptomes and epigenomes at high speeds and with a degree of clarity never before thought possible.
But preparing samples for sequencing is no small piece of the puzzle, as is evidenced by the growing number of companies that are jumping onto the NGS sample preparation bandwagon.
NGS Sample Prep Market Scan: Pinpointing Customer Needs and Opportunities for Growth targets the manufacturers and suppliers of NGS sample prep to help identify the usage, preferences and differentiators in a market that has attracted a significant number of players.
Suppliers recognize that there are fewer barriers to entry in the sample prep space compared to developing new sequencing platforms, thereby making sample prep product development more attractive—and on the rise.
Inherent in the sample prep market are multiple opportunities to address differences in sequencing platforms, methods of DNA fragmentation and, ultimately, the conversion of DNA or RNA samples into application-specific NGS libraries.
In this study, we will identify bottlenecks and areas that are causing the most frustration to researchers, but also point directly to opportunities for innovation.
We will cover areas of growth by application, segment and region. We will also examine how automation can conceivably change the speed, consistency, accuracy and ease with which researchers can expect to conduct next generation sequencing now and in the future.
With so many suppliers to choose from, how can a single supplier stand out? The foundation of a successful differentiation strategy is often a detailed understanding of the external environment.
In this report, we will
- Identify the competitive mix by brand in the top product categories
-DNA libraries: whole genome, ChIP and methylated DNA
-Targeted resequencing: exome and panels
-RNA libraries: total RNA, mRNA and small RNA - Determine the key drivers of customer satisfaction in each product category
- Gain insights into customer satisfaction and loyalty
With literally hundreds of products available from dozens of suppliers, the ability to fine-tune your unique message, value proposition and product portfolio is more important than ever.
Report Overview Video
For more information on this report, contact:
Devin Holland
Content Marketing Associate
BioInformatics LLC
703.778.3080 ext. 14
info@gene2drug.com
www.gene2drug.com
